Scarica l'app Stockscreener
25.58
2.90%
0.72
Dopo l'orario di chiusura:
25.65
0.07
+0.27%
Forte Biosciences Inc Borsa (FBRX) Ultime notizie
Tech Rally: Is Forte Biosciences Inc trading at a discount2026 Pullbacks & Safe Entry Trade Reports - baoquankhu1.vn
Published on: 2026-04-05 11:22:35 - baoquankhu1.vn
Precision Trading with Forte Biosciences Inc. (FBRX) Risk Zones - Stock Traders Daily
Forte Biosciences and Pasithea Therapeutics Face Off in Financial Comparison - National Today
Forte Biosciences (NASDAQ: FBRX) CFO exercises RSUs, 134 shares withheld - Stock Titan
Forte Biosciences (FBRX) director boosts stake after RSU vesting - Stock Titan
Guggenheim reiterates Forte Biosciences stock rating ahead of data - Investing.com
Guggenheim reiterates Forte Biosciences stock rating ahead of data By Investing.com - Investing.com UK
Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - marketbeat.com
Forte Biosciences Reports 2025 Financial Results and Provides FB102 Clinical Development Updates for Celiac Disease, Vitiligo, and Alopecia Areata - Minichart
FB102 trials drive higher 2025 R&D at Forte Biosciences (NASDAQ: FBRX) - Stock Titan
Forte Biosciences (NASDAQ:FBRX) Announces Quarterly Earnings Results - marketbeat.com
Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Forte Biosciences (NASDAQ: FBRX) advances FB102 with positive celiac data and funds trials through equity raises - Stock Titan
Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Forte Biosciences, Inc. Announces 2025 Results and Provides Update - The Joplin Globe
Three FB102 disease readouts are due in 2026 after Forte spent $58M - Stock Titan
Reviewing Pasithea Therapeutics (NASDAQ:KTTA) and Forte Biosciences (NASDAQ:FBRX) - Defense World
FBRX Stock Price, Quote & Chart | FORTE BIOSCIENCES INC (NASDAQ:FBRX) - ChartMill
Forte Biosciences, Inc.: Fundamental Analysis and Financial Ratings | | US34962G2084 - MarketScreener
Technical Reactions to FBRX Trends in Macro Strategies - Stock Traders Daily
Rally Mode: Is Forte Biosciences Inc a top pick in the sectorEarnings Miss & Growth Oriented Trade Recommendations - baoquankhu1.vn
Forte Biosciences Inc expected to post a loss of $1.21 a shareEarnings Preview - tradingview.com
Pullback Watch: Will Forte Biosciences Inc announce a stock splitQuarterly Performance Summary & High Win Rate Trade Tips - baoquankhu1.vn
If You Invested $1,000 in Forte Biosciences Inc (FBRX) - Stock Titan
Forte Biosciences (FBRX) Projected to Post Earnings on Friday - marketbeat.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat
Aug Fed Impact: Does Forte Biosciences Inc have pricing power2026 Price Targets & Growth Focused Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - The Joplin Globe
Mink Brook Asset Management LLC Buys 42,419 Shares of Forte Biosciences, Inc. $FBRX - MarketBeat
New hires at Forte Biosciences get options on 25,000 shares - Stock Titan
Trading the Move, Not the Narrative: (FBRX) Edition - Stock Traders Daily
History Review: Can Forte Biosciences Inc maintain its current growth rateGap Up & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
FBRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FBRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bank Watch: Can LOKV lead its sector in growth2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
Can Forte Biosciences Inc. stock beat analyst upgradesEarnings Beat & Growth Focused Stock Pick Reports - Naître et grandir
Can Forte Biosciences Inc. stock maintain growth trajectoryWeekly Loss Report & Technical Confirmation Alerts - Naître et grandir
Portfolio Update: Can MKTW withstand a market correction2025 Analyst Calls & Community Verified Trade Alerts - baoquankhu1.vn
Forte Biosciences (FBRX) Price Target Increased by 16.98% to 53.30 - MSN
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules - marketscreener.com
Vitiligo Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com
Stock Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Biotech Forte Biosciences hands 100,000 stock options to new hires - Stock Titan
Celiac Disease Market: Expanding Revenue Landscape to 2034 – DelveInsight | Zedira, Dr. Falk Pharma, Takeda, ImmunoGenX, Provention Bio, Sanofi, Topas Therapeutics GmbH, Pfizer - StreetInsider
(FBRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
FBRX PE Ratio & Valuation, Is FBRX Overvalued - Intellectia AI
Forte Biosciences (FBRX) Raised to Buy: Key Information You Need - Bitget
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Pullback Watch: Is Forte Biosciences Inc a top pick in the sector2025 Risk Factors & Low Volatility Stock Suggestions - baoquankhu1.vn
Is Forte Biosciences Inc. a top pick in the sectorWeekly Stock Summary & Weekly Watchlist for Hot Stocks - mfd.ru
Will Forte Biosciences Inc. benefit from rate cutsQuarterly Portfolio Report & Stepwise Swing Trade Plans - mfd.ru
Price-Driven Insight from (FBRX) for Rule-Based Strategy - Stock Traders Daily
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Analyst Downgrade: Is Forte Biosciences Inc stock a good dividend stockCEO Change & Growth Focused Entry Reports - baoquankhu1.vn
We Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business Growth - Yahoo Finance
Celiac Disease Clinical Trial Pipeline Gains Momentum as 25+ - openPR.com
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):